Published in Trends Parasitol on February 01, 2005
Genome sequence of the stramenopile Blastocystis, a human anaerobic parasite. Genome Biol (2011) 1.36
Mitosomes in Entamoeba histolytica contain a sulfate activation pathway. Proc Natl Acad Sci U S A (2009) 1.26
Lipoic acid metabolism in microbial pathogens. Microbiol Mol Biol Rev (2010) 1.18
Patterns of kinesin evolution reveal a complex ancestral eukaryote with a multifunctional cytoskeleton. BMC Evol Biol (2010) 1.17
Evolution of macromolecular import pathways in mitochondria, hydrogenosomes and mitosomes. Philos Trans R Soc Lond B Biol Sci (2010) 1.06
Diversity and origins of anaerobic metabolism in mitochondria and related organelles. Philos Trans R Soc Lond B Biol Sci (2015) 0.82
Novel Hydrogenosomes in the Microaerophilic Jakobid Stygiella incarcerata. Mol Biol Evol (2016) 0.79
A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis. PLoS Negl Trop Dis (2017) 0.78
Identification and characterization of a mitochondrial iron-superoxide dismutase of Cryptosporidium parvum. Parasitol Res (2008) 0.76
Reading the Evolution of Compartmentalization in the Ribosome Assembly Toolbox: The YRG Protein Family. PLoS One (2017) 0.75
Sequence Analysis of Mitochondrial Genome of Toxascaris leonina from a South China Tiger. Korean J Parasitol (2016) 0.75
Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening. Am J Obstet Gynecol (2005) 2.66
Discovery of novel intermediate forms redefines the fungal tree of life. Nature (2011) 2.37
Multiple marker parallel tag environmental DNA sequencing reveals a highly complex eukaryotic community in marine anoxic water. Mol Ecol (2010) 2.33
Algal genomes reveal evolutionary mosaicism and the fate of nucleomorphs. Nature (2012) 2.15
Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin Infect Dis (2011) 1.87
Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans. Vaccine (2010) 1.61
Toxoplasma gondii tachyzoite-bradyzoite interconversion. Trends Parasitol (2002) 1.58
NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells. Infect Immun (2010) 1.46
Evolutionary origins of the eukaryotic shikimate pathway: gene fusions, horizontal gene transfer, and endosymbiotic replacements. Eukaryot Cell (2006) 1.44
Insights from sequencing fungal and oomycete genomes: what can we learn about plant disease and the evolution of pathogenicity? Plant Cell (2007) 1.43
Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J Neuroinflammation (2008) 1.41
Histological evidence of tissue reaction to gold weights used for mechanical ptosis. Arch Ophthalmol (2010) 1.41
Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz (2009) 1.39
Maternal inheritance and stage-specific variation of the apicoplast in Toxoplasma gondii during development in the intermediate and definitive host. Eukaryot Cell (2005) 1.37
P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages. J Immunol (2010) 1.33
Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. PLoS One (2008) 1.32
Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy. Arch Ophthalmol (2008) 1.30
Identification of a sporozoite-specific antigen from Toxoplasma gondii. J Parasitol (2011) 1.28
IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii. Eur J Immunol (2010) 1.27
The shikimate pathway and its branches in apicomplexan parasites. J Infect Dis (2002) 1.25
Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. Pediatr Infect Dis J (2011) 1.25
Horizontal gene transfer and the evolution of parasitic protozoa. Protist (2003) 1.24
Newly identified and diverse plastid-bearing branch on the eukaryotic tree of life. Proc Natl Acad Sci U S A (2011) 1.19
DNA evidence for global dispersal and probable endemicity of protozoa. BMC Evol Biol (2007) 1.18
Patterns of kinesin evolution reveal a complex ancestral eukaryote with a multifunctional cytoskeleton. BMC Evol Biol (2010) 1.17
Ancient diversification of eukaryotic MCM DNA replication proteins. BMC Evol Biol (2009) 1.17
Parasite regulation by host hormones: an old mechanism of host exploitation? Trends Parasitol (2005) 1.16
Yeast forms dominate fungal diversity in the deep oceans. Proc Biol Sci (2007) 1.14
Clinical manifestations of ocular toxoplasmosis. Ocul Immunol Inflamm (2011) 1.13
Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo. PLoS Negl Trop Dis (2008) 1.10
Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies. Pediatrics (2006) 1.10
Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis (2011) 1.09
Expression, purification and crystallization of the Plasmodium falciparum enoyl reductase. Acta Crystallogr D Biol Crystallogr (2003) 1.09
Longitudinal study of new eye lesions in treated congenital toxoplasmosis. Ophthalmology (2007) 1.09
A thyroglossal duct cyst of the anterior mediastinum. Ann Thorac Surg (2011) 1.07
Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway. Antimicrob Agents Chemother (2012) 1.07
Validation and justification of the phylum name Cryptomycota phyl. nov. IMA Fungus (2011) 1.05
The T1799A BRAF mutation is present in iris melanoma. Invest Ophthalmol Vis Sci (2007) 1.05
Horizontal gene transfer in eukaryotic plant pathogens. Annu Rev Phytopathol (2014) 1.04
Genetic analysis of influences on survival following Toxoplasma gondii infection. Int J Parasitol (2002) 1.04
Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201. Vaccine (2010) 1.04
Oral oocyst-induced mouse model of toxoplasmosis: effect of infection with Toxoplasma gondii strains of different genotypes, dose, and mouse strains (transgenic, out-bred, in-bred) on pathogenesis and mortality. Parasitology (2011) 1.02
Evolution and classification of myosins, a paneukaryotic whole-genome approach. Genome Biol Evol (2014) 1.02
Development of colorimetric microtiter plate assay for assessment of antimicrobials against Acanthamoeba. J Clin Microbiol (2005) 1.01
Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. Am J Ophthalmol (2008) 1.00
BRAF mutations in conjunctival melanoma. Invest Ophthalmol Vis Sci (2004) 1.00
Lipidomic analysis of Toxoplasma gondii reveals unusual polar lipids. Biochemistry (2007) 1.00
Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors. Immunology (2008) 0.99
Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents. Acta Crystallogr D Biol Crystallogr (2007) 0.98
Cataracts in congenital toxoplasmosis. J AAPOS (2007) 0.98
In vitro correlates of Ld-restricted resistance to toxoplasmic encephalitis and their critical dependence on parasite strain. J Immunol (2002) 0.97
T. gondii RP promoters & knockdown reveal molecular pathways associated with proliferation and cell-cycle arrest. PLoS One (2010) 0.96
Evolution of the Isd11-IscS complex reveals a single alpha-proteobacterial endosymbiosis for all eukaryotes. Mol Biol Evol (2006) 0.96
Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections. Proc Natl Acad Sci U S A (2012) 0.95
Evidence for mitochondrial-derived alternative oxidase in the apicomplexan parasite Cryptosporidium parvum: a potential anti-microbial agent target. Int J Parasitol (2004) 0.95
Identification and development of novel inhibitors of Toxoplasma gondii enoyl reductase. J Med Chem (2010) 0.95
Host genetic and epigenetic factors in toxoplasmosis. Mem Inst Oswaldo Cruz (2009) 0.95
Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice. Hum Immunol (2011) 0.94
Correlation of heterogeneity for chromosome 3 copy number with cell type in choroidal melanoma of mixed-cell type. Invest Ophthalmol Vis Sci (2006) 0.94
Ancient animal ancestry for nuclear myosin. J Cell Sci (2009) 0.93
Differential modulation of TLR3- and TLR4-mediated dendritic cell maturation and function by progesterone. J Immunol (2010) 0.93
Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo. Antimicrob Agents Chemother (2005) 0.92
Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows. Eur J Nucl Med Mol Imaging (2005) 0.91
Observational prospective cohort study of patients with newly-diagnosed ocular sebaceous carcinoma. Br J Ophthalmol (2012) 0.90
Severe fascioscapulohumeral muscular dystrophy presenting with Coats' disease and mental retardation. Neuromuscul Disord (2006) 0.89
Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful. Am J Clin Pathol (2006) 0.89
Salicylanilide inhibitors of Toxoplasma gondii. J Med Chem (2012) 0.87
Genome-scale comparative analysis of gene fusions, gene fissions, and the fungal tree of life. Proc Natl Acad Sci U S A (2012) 0.87
Metastases to breast from primary lung cancer. J Thorac Oncol (2009) 0.87
REFGEN and TREENAMER: automated sequence data handling for phylogenetic analysis in the genomic era. Evol Bioinform Online (2009) 0.87
A case of interface keratitis following anterior lamellar keratoplasty. Surv Ophthalmol (2012) 0.86
Toxoplasma gondii-specific immunoglobulin M limits parasite dissemination by preventing host cell invasion. Infect Immun (2005) 0.86
Gene transfer: anything goes in plant mitochondria. BMC Biol (2010) 0.86
Periocular steroids in conjunctival reactive lymphoid hyperplasia, a new approach? Clin Experiment Ophthalmol (2011) 0.86
Peripheral ulcerative keratitis due to a 'long lost' hard contact lens. Clin Experiment Ophthalmol (2007) 0.86
Diverse molecular signatures for ribosomally 'active' Perkinsea in marine sediments. BMC Microbiol (2014) 0.84
Immunological control of congenital toxoplasmosis in the murine model. Immunol Lett (2007) 0.84
Immunogenetics of Toxoplasma gondii informs vaccine design. Trends Parasitol (2010) 0.84
Selective inhibition and augmentation of alternative macrophage activation by progesterone. Immunology (2011) 0.84
Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase. Bioorg Med Chem Lett (2013) 0.84